Baduanjin’s slow, structured movements delivered reductions similar to certain medications, offering a scalable option for long-term heart health.

A single intravenous dose of dimethyltryptamine, the psychoactive compound found in the Amazonian brew ayahuasca, produced significant and lasting reductions in depression symptoms across a ...

Early findings from the ongoing MIRACLE clinical trial suggest that the investigational drug annamycin, given with cytarabine, may help more patients with relapsed or refractory acute myeloid leukemia ...

Lunai Bioworks (NASDAQ: LNAI) has launched a new oncology collaboration with a clinical-stage partner to apply artificial intelligence to data from a randomized Phase 2 trial in metastatic colorectal ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Awareness and understanding of misophonia are growing. Here are five key advances that are pushing the field forward.

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

The Encora X1 utilizes proprietary algorithms to analyze a patient’s tremor in real time. It delivers targeted stimulation to the wrist, modulating the neural pathways responsible for the tremor. The ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra ® across nine diverse patients ...

New research shows that 30-second bursts of intense cardio can reduce panic symptoms by teaching your nervous system that ...